December 8, 2025Blood

Early peripheral blood blast clearance is a prognostic marker for early treatment response and long-term outcome in pediatric Acute Myeloid Leukemia

View Full Paper

Ask AI

Bookmark

Authors

BBBianca de Boer KKKim Klein BGBianca F. Goemans

Discussion

Member takes

Implication

Observational analysis found early peripheral blood blast clearance predicts treatment response in pediatric AML, suggesting a viable alternative to bone marrow assessments.

Key Points

Early peripheral blood blast clearance is a promising prognostic marker for pediatric acute myeloid leukemia.
Patients achieving clearance within 9 days showed a predicted probability of 84.2% overall survival.
Data was collected from pediatric patients treated under the NOPHO-DBH AML-2012 protocol across multiple countries.
This non-invasive approach may enhance monitoring and outcomes in low-resource settings.

Cite This Study

Boer et al. (2025) studied this question.

synapsesocial.com/papers/69362f6c4fa91c937236e048 https://doi.org/10.1182/blood-2025-5261

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis found early peripheral blood blast clearance predicts treatment response in pediatric AML, suggesting a viable alternative to bone marrow assessments.

Early peripheral blood blast clearance is a prognostic marker for early treatment response and long-term outcome in pediatric Acute Myeloid Leukemia

Discussion

Member takes

Implication

Key Points

Cite This Study

Early peripheral blood blast clearance is a prognostic marker for early treatment response and long-term outcome in pediatric Acute Myeloid Leukemia

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider